Suchergebnisse - "CRS"

PubPharm (71)

51

Blood ozonization in patients with mild to moderate COVID-19 pneumonia : a single centre experience

enthalten in: Internal and emergency medicine | 2021

von Tascini, C. | Sermann, G. | Pagotto, A. | +10

CommentIn: Intern Emerg Med. 2021 Apr;16(3):793-794. - PMID 33400161

52

Tocilizumab for severe COVID-19 related illness - A community academic medical center experience

enthalten in: Cytokine: X | 2020

von Meleveedu, K. | Miskovsky, J. | Meharg, J. | +12

53

Convalescent plasma therapy and remdesivir duo successfully salvaged an early liver transplant recipient with severe COVID-19 pneumonia

enthalten in: Annals of hepato-biliary-pancreatic surgery | 2020

von Jamir, I. | Lohia, P. | Pande, R. | +3

54

Headache as a Prognostic Factor for COVID-19. Time to Re-evaluate

enthalten in: SN comprehensive clinical medicine | 2020

von Martelletti, P. | Bentivegna, E. | Luciani, M. | +1

55

Headache as a Prognostic Factor for COVID-19. Time to Re-evaluate

enthalten in: SN comprehensive clinical medicine | 2020

von Martelletti, P. | Bentivegna, E. | Luciani, M. | +1

56

Icosapent Ethyl (Vascepa®) for the Treatment of Acute, Severe Pancreatitis

enthalten in: Cureus | 2020

von Berger, A. | Sherburne, R. | Urits, I. | +2

57

COVID-19 Infection in a Patient With Fragile-X Syndrome

enthalten in: Cureus | 2020

von Kleiman, J. | Veerapaneni, K. | Escovar, J. | +1

58

A Systematic Review and Meta-Analysis of Hospitalised Current Smokers and COVID-19

enthalten in: International journal of environmental research and public health | 2020

von González-Rubio, J. | Navarro-López, C. | López-Nájera, E. | +4

CommentIn: Int J Environ Res Public Health. 2020 Dec 21;17(24):. - PMID 33371212

59

A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Ascending Doses of GP1681 in Healthy Adult Participants : A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Ascending Doses of GP1681 in Healthy Adult Participants

enthalten in: WHO International Clinical Trials Registry Platform | 2020

60

A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Ascending Doses of GP1681 in Healthy Adult Participants : A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Ascending Doses of GP1681 in Healthy Adult Participants

enthalten in: WHO International Clinical Trials Registry Platform | 2020